At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
HAART 300 Annuloplasty Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Non-randomized, Multi-center Trial to Evaluate the Safety and Effectiveness of the HAART Model 300 Annuloplasty Ring When Used to Surgically Repair a Leaking Aortic Valve Using a 3-D Intra-annular Mounting Frame
In Brief
A clinical study evaluating HAART 300 Annuloplasty Device for Aortic Regurgitation. Completed, enrolled 18 participants across 4 sites in 3 countries.
Detailed Summary
This investigation is a prospective, non-randomized, multi-center trial to evaluate the safety and effectiveness of the HAART model 300 annuloplasty ring when used to surgically repair a leaking aortic valve using a 3-D intra-annular mounting frame
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Regurgitation
CountriesBelgium, Czechia, Germany
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 2011
Enrollment StartJan 2012
Primary CompletionApr 2013
Study CompletionSep 2014
TodayJul 2026
First PostedJul 22, 2011
Enrollment StartJan 1, 2012
Primary CompletionApr 1, 2013
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.9 years ago
Interventions
HAART 300 Annuloplasty Devicedevice
Implantation of device for aortic valve repair